Programmatic Research
“Programmatic, basic and translational studies are the bedrock of scientific research at Jefferson, and we are continuing to build on our areas of great strength. These include nationally recognized programs in cancer mechanisms and immunotherapies, neurodevelopment and neurodegeneration, infectious diseases and vaccines, fibrotic disease and RNA biology. We will launch other initiatives in highly promising areas as well—and, working across disciplines and disease areas, we are committed to having real impact in reducing disparities in care and addressing the nonbiological causes of disease. To empower our investigators, we will continue making major investments in new research technologies—capitalizing, for example, on recent acquisitions of flow cytometry and cryo-EM systems, expanding our bioinformatics infrastructure, and making large-scale additions to the laboratories and core facilities available to our investigators."